Advertisement
Canada markets close in 3 hours 41 minutes

  • S&P/TSX

    21,846.16
    -165.56 (-0.75%)
     

  • S&P 500

    5,053.07
    -17.48 (-0.34%)
     

  • DOW

    38,372.13
    -131.56 (-0.34%)
     

  • CAD/USD

    0.7289
    -0.0031 (-0.42%)
     

  • CRUDE OIL

    82.88
    -0.48 (-0.58%)
     

  • Bitcoin CAD

    88,654.13
    -2,865.09 (-3.13%)
     

  • CMC Crypto 200

    1,398.99
    -25.11 (-1.77%)
     

  • GOLD FUTURES

    2,336.80
    -5.30 (-0.23%)
     

  • RUSSELL 2000

    1,985.53
    -17.11 (-0.85%)
     

  • 10-Yr Bond

    4.6540
    +0.0560 (+1.22%)
     

  • NASDAQ

    15,657.66
    -38.98 (-0.25%)
     

  • VOLATILITY

    16.11
    +0.42 (+2.67%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • CAD/EUR

    0.6817
    -0.0019 (-0.28%)
     
MARKETS LIVE BLOG:

STOCKS SHED GAINS, TESLA SURGES DAY AFTER EARNINGS

Tesla shares jump after EV maker vows to speed up launch of more affordable models

Collegium to Report First Quarter 2023 Financial Results on May 4, 2023

Collegium Pharmaceutical, Inc.
·1 min read
Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc.

STOUGHTON, Mass., April 20, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it will report first quarter 2023 financial results after the market closes on Thursday, May 4, 2023. Following the release of the financials, the Company will host a live conference call and webcast at 4:30 p.m. ET.

Conference Call Information 
To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q1 2023 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately two hours after the event.

About Collegium Pharmaceutical, Inc.
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.

ADVERTISEMENT

Investor Contact:
Christopher James, M.D.                                                                                       
Vice President, Investor Relations
ir@collegiumpharma.com

Media Contact:
Marissa Samuels
Vice President, Corporate Communications
communications@collegiumpharma.com